Source: http://health.yahoo.net/news/s/nm/aastrom-biosciences-ends-drug-trial-to-cut-half-its-workforce
Friday, 29 March 2013
Aastrom Biosciences ends drug trial, to cut half its workforce
By Vrinda Manocha (Reuters) - Aastrom Biosciences Inc said it would end the late-stage trial of its drug to treat critical limb ischemia (CLI), a form of peripheral arterial disease, and cut about half of its workforce, driving its shares to an al...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: only a member of this blog may post a comment.